All Featured Insights

This week, we hear the conclusion of host J. Carlisle Larsen’s conversation with CHAI CEO Brian Anderson, M.D., about his organization’s work with the Joint Commission to establish best practices for the use of AI tools within healthcare.

Hospital financial indicators were slightly weaker in May than the previous month, with a greater decline in month-over-month outpatient revenue than recorded recently.

A recent Vizient benchmarking survey found the top barrier to implementing AI is a lack of clear return on investment. A successful AI strategy must include a clear prioritization framework and a deeper understanding of value.

Hospital performance improved between January and April, and on a year-to-date basis, performance in the first four months of 2025 compared favorably to the same period in 2024.

Daily patient volumes decreased due to declines in flu and other seasonal infectious diseases, contributing to a decline in hospital care expenses despite elevated overall expenses.

UnitedHealth Group stock drops, eight artificial food dyes to be phased out, Eli Lilly oral GLP-1 pill has promising Phase 3 result

As Medicaid cuts look increasingly likely per Congress’ recently-passed budget plan, this week’s graphic uses survey data from KFF to take stock of the public’s view of the program.

Performance in February has remained stable. Volumes stayed strong, including in emergency departments. Non-labor expenses have been the primary driver of expense growth thus far in 2025.

HHS announces major restructuring, two Trump healthcare picks confirmed, 23andMe files for bankruptcy.

Hospital performance remains stable at the start of 2025. Inpatient revenue grew more quickly than outpatient revenue in January, and the rate of cost growth has slowed considerably.

A deeper dive into Kaufman Hall’s National Hospital Flash Report data provides important lessons in the management of departmental performance and shared services costs.

RFK Jr. clears Senate panel, federal and state policy battle over transgender care comes to head in New York, Moody’s downgrades health insurer credit outlook